Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06264804Recruiting

Risk Factors for Progressive Suction Loss in Corneal Refractive Surgery

Role: lead

NCT05476068Completed

Dry Eye Under China's Dynamic COVID-zero Strategy

Role: lead

NCT05367154Completed

Factor Analysis of Unintended Initial Dissection of the Posterior Plane

Role: lead

NCT05362253Not ApplicableCompleted

Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial

Role: lead

All 4 trials loaded